Nano Announces Lead Investor Commitment for $90 Million Funding Round
Investment will accelerate scale up of Nano’s platform to expand vaccine access and alternate delivery. AUSTIN, Texas and DUBAI, UAE (Arab Newswire) -- Nano Cures Inc. (“ Nano ”), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating. The investment will accelerate the global scale up of Nano’s Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery. Nano’s novel self- administered technology moves delivery beyond syringes and shots, to an array of nasal, dermal, ophthalmic, sub-lingual, and oral options. Nano will open up its Cures Platform to other pharmaceutical companies and their vaccines, providing dynamic new ways to con...